U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050459) titled 'A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors' on May 27.
Brief Summary: This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0686 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
Study Start Date: May 20
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Solid Tumors
Intervention:
DRUG: SIM0686
Administered intravenously
DRUG: SIM0686
Administered intravenously
Recruitment Status: RECRUITING
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Disclaimer: Curated by HT...